ID   ZN383_HUMAN             Reviewed;         475 AA.
AC   Q8NA42; Q6X2C7;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   28-JUN-2023, entry version 162.
DE   RecName: Full=Zinc finger protein 383;
GN   Name=ZNF383; ORFNames=HSD17;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   TISSUE=Embryonic heart;
RX   PubMed=15964543; DOI=10.1016/j.bbrc.2005.05.193;
RA   Cao L., Wang Z., Zhu C., Zhao Y., Yuan W., Li J., Wang Y., Ying Z., Li Y.,
RA   Yu W., Wu X., Liu M.;
RT   "ZNF383, a novel KRAB-containing zinc finger protein, suppresses MAPK
RT   signaling pathway.";
RL   Biochem. Biophys. Res. Commun. 333:1050-1059(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RA   Hu T.H., Miao S.Y., Zhang X.D., Qiao Y., Liang G., Wang L.F.;
RT   "A new spermatogenesis-related gene.";
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -!- FUNCTION: May function as a transcriptional repressor, suppressing
CC       transcriptional activities mediated by MAPK signaling pathways.
CC       {ECO:0000269|PubMed:15964543}.
CC   -!- INTERACTION:
CC       Q8NA42; O94818-2: NOL4; NbExp=3; IntAct=EBI-20110775, EBI-10190763;
CC       Q8NA42; Q9P2K3-2: RCOR3; NbExp=3; IntAct=EBI-20110775, EBI-1504830;
CC       Q8NA42; Q08117-2: TLE5; NbExp=3; IntAct=EBI-20110775, EBI-11741437;
CC       Q8NA42; Q9NZV7: ZIM2; NbExp=3; IntAct=EBI-20110775, EBI-11962760;
CC       Q8NA42; Q7Z3I7: ZNF572; NbExp=3; IntAct=EBI-20110775, EBI-10172590;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15964543}. Cytoplasm
CC       {ECO:0000269|PubMed:15964543}. Note=Shuttling between the nucleus and
CC       cytoplasm may occur under different stimulation and growth conditions.
CC   -!- TISSUE SPECIFICITY: Expressed in heart, placenta, liver, pancreas and
CC       with a higher level in skeletal muscle. {ECO:0000269|PubMed:15964543}.
CC   -!- DEVELOPMENTAL STAGE: In tissues from a six months embryo, highly
CC       expressed in heart, testis and skeletal muscle, lower expression levels
CC       in kidney, intestines and prostate. {ECO:0000269|PubMed:15964543}.
CC   -!- DOMAIN: The KRAB domain is responsible for the transcriptional
CC       repressor activity.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY438646; AAR14184.1; -; mRNA.
DR   EMBL; AY260141; AAP20067.1; -; mRNA.
DR   EMBL; AK093182; BAC04086.1; -; mRNA.
DR   CCDS; CCDS12501.1; -.
DR   RefSeq; NP_001332876.1; NM_001345947.1.
DR   RefSeq; NP_001332877.1; NM_001345948.1.
DR   RefSeq; NP_001332878.1; NM_001345949.1.
DR   RefSeq; NP_689817.1; NM_152604.2.
DR   RefSeq; XP_005258642.1; XM_005258585.2.
DR   RefSeq; XP_011524888.1; XM_011526586.2.
DR   RefSeq; XP_011524889.1; XM_011526587.2.
DR   RefSeq; XP_011524890.1; XM_011526588.2.
DR   RefSeq; XP_011524891.1; XM_011526589.2.
DR   RefSeq; XP_011524892.1; XM_011526590.2.
DR   RefSeq; XP_016881911.1; XM_017026422.1.
DR   RefSeq; XP_016881912.1; XM_017026423.1.
DR   RefSeq; XP_016881913.1; XM_017026424.1.
DR   AlphaFoldDB; Q8NA42; -.
DR   SMR; Q8NA42; -.
DR   BioGRID; 127849; 21.
DR   IntAct; Q8NA42; 6.
DR   STRING; 9606.ENSP00000340132; -.
DR   GlyGen; Q8NA42; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q8NA42; -.
DR   PhosphoSitePlus; Q8NA42; -.
DR   BioMuta; ZNF383; -.
DR   DMDM; 74760056; -.
DR   jPOST; Q8NA42; -.
DR   MassIVE; Q8NA42; -.
DR   MaxQB; Q8NA42; -.
DR   PaxDb; Q8NA42; -.
DR   PeptideAtlas; Q8NA42; -.
DR   ProteomicsDB; 72635; -.
DR   Antibodypedia; 29883; 66 antibodies from 13 providers.
DR   DNASU; 163087; -.
DR   Ensembl; ENST00000352998.7; ENSP00000340132.2; ENSG00000188283.12.
DR   Ensembl; ENST00000589413.5; ENSP00000464871.1; ENSG00000188283.12.
DR   Ensembl; ENST00000590503.5; ENSP00000466101.1; ENSG00000188283.12.
DR   Ensembl; ENST00000684119.1; ENSP00000507972.1; ENSG00000188283.12.
DR   GeneID; 163087; -.
DR   KEGG; hsa:163087; -.
DR   MANE-Select; ENST00000684119.1; ENSP00000507972.1; NM_001387601.1; NP_001374530.1.
DR   UCSC; uc002oft.2; human.
DR   AGR; HGNC:18609; -.
DR   CTD; 163087; -.
DR   DisGeNET; 163087; -.
DR   GeneCards; ZNF383; -.
DR   HGNC; HGNC:18609; ZNF383.
DR   HPA; ENSG00000188283; Low tissue specificity.
DR   MIM; 619499; gene.
DR   neXtProt; NX_Q8NA42; -.
DR   OpenTargets; ENSG00000188283; -.
DR   PharmGKB; PA134903145; -.
DR   VEuPathDB; HostDB:ENSG00000188283; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000156284; -.
DR   HOGENOM; CLU_002678_0_10_1; -.
DR   InParanoid; Q8NA42; -.
DR   OMA; ESCQREM; -.
DR   OrthoDB; 3120634at2759; -.
DR   PhylomeDB; Q8NA42; -.
DR   PathwayCommons; Q8NA42; -.
DR   Reactome; R-HSA-212436; Generic Transcription Pathway.
DR   SignaLink; Q8NA42; -.
DR   BioGRID-ORCS; 163087; 18 hits in 1145 CRISPR screens.
DR   ChiTaRS; ZNF383; human.
DR   GenomeRNAi; 163087; -.
DR   Pharos; Q8NA42; Tdark.
DR   PRO; PR:Q8NA42; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q8NA42; protein.
DR   Bgee; ENSG00000188283; Expressed in granulocyte and 121 other tissues.
DR   ExpressionAtlas; Q8NA42; baseline and differential.
DR   Genevisible; Q8NA42; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0031965; C:nuclear membrane; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   Gene3D; 6.10.140.140; -; 1.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 11.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR24377; IP01015P-RELATED; 1.
DR   PANTHER; PTHR24377:SF980; ZINC FINGER PROTEIN 420; 1.
DR   Pfam; PF01352; KRAB; 1.
DR   Pfam; PF00096; zf-C2H2; 8.
DR   Pfam; PF13465; zf-H2C2_2; 1.
DR   SMART; SM00349; KRAB; 1.
DR   SMART; SM00355; ZnF_C2H2; 11.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 6.
DR   SUPFAM; SSF109640; KRAB domain (Kruppel-associated box); 1.
DR   PROSITE; PS50805; KRAB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 11.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 11.
PE   1: Evidence at protein level;
KW   Cytoplasm; DNA-binding; Metal-binding; Nucleus; Reference proteome; Repeat;
KW   Transcription; Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN           1..475
FT                   /note="Zinc finger protein 383"
FT                   /id="PRO_0000047550"
FT   DOMAIN          6..77
FT                   /note="KRAB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00119"
FT   ZN_FING         170..192
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         198..220
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         226..248
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         254..276
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         282..304
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         310..332
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         338..360
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         366..388
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         394..416
FT                   /note="C2H2-type 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         422..444
FT                   /note="C2H2-type 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         450..472
FT                   /note="C2H2-type 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   CONFLICT        11
FT                   /note="V -> A (in Ref. 2; AAP20067)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        114
FT                   /note="Y -> H (in Ref. 2; AAP20067)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        443
FT                   /note="I -> V (in Ref. 2; AAP20067)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   475 AA;  54613 MW;  2F47070F5C2E582B CRC64;
     MAEGSVMFSD VSIDFSQEEW DCLDPVQRDL YRDVMLENYG NLVSMGLYTP KPQVISLLEQ
     GKEPWMVGRE LTRGLCSDLE SMCETKLLSL KKEVYEIELC QREIMGLTKH GLEYSSFGDV
     LEYRSHLAKQ LGYPNGHFSQ EIFTPEYMPT FIQQTFLTLH QIINNEDRPY ECKKCGKAFS
     QNSQFIQHQR IHIGEKSYEC KECGKFFSCG SHVTRHLKIH TGEKPFECKE CGKAFSCSSY
     LSQHQRIHTG KKPYECKECG KAFSYCSNLI DHQRIHTGEK PYECKVCGKA FTKSSQLFQH
     ARIHTGEKPY ECKECGKAFT QSSKLVQHQR IHTGEKPYEC KECGKAFSSG SALTNHQRIH
     TGEKPYDCKE CGKAFTQSSQ LRQHQRIHAG EKPFECLECG KAFTQNSQLF QHQRIHTDEK
     PYECNECGKA FNKCSNLTRH LRIHTGEKPY NCKECGKAFS SGSDLIRHQG IHTNK
//
